Effects of Bacteroides asaccharolyticus cells and B. fragilis surface components on serum opsonisation and phagocytosis

References

1. Bjornson A. B. 1984; Role of complement in host resistance against members of the Bacteroidaceae. Reviews of Infectious Diseases 6: suppl 134–39
   [Google Scholar]
2. Bjornson A. B., Bjornson H. S., Ashraf M., Lang T. J. 1983; Quantitative variability in requirements for opsonization of strains within the Bacteroides fragilis group. Journal of Infectious Diseases 148:667–675
   [Google Scholar]
3. Connolly McLean C., Tabaqchali S. 1984; The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing. Journal of Medical Microbiology 17:1259–1271
   [Google Scholar]
4. Dhingra R. K., Williams R. L., Reed W. P. 1977; Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis. Infection and Immunity 15:169–174
   [Google Scholar]
5. Ingham H. R., Sisson P. R., Middleton R. L., Narang H. K., Codd A. A., Selkon J. B. 1981; Phagocytosis and killing of bacteria in aerobic and anaerobic conditions. Journal of Medical Microbiology 14:391–399
   [Google Scholar]
6. Ingham H. R., Sisson P. R., Tharagonnet D., Selkon J. B., Codd A. A. 1977; Inhibition of phagocytosis in vitro by obligate anaerobes. Lancet 2:1252–1254
   [Google Scholar]
7. Joiner Hawiger A., Gelfand J. A. 1981; Activation of the alternative complement pathway by blood culture isolates of Bacteroides fragilis . Infection and Immunity 34:303–305
   [Google Scholar]
8. Jones Gemmell C. G. 1982; Impairment by Bacteroides species of opsonisation and phagocytosis of enterobacteria. Journal of Medical Microbiology 15:351–361
   [Google Scholar]
9. Kasper D. L., Onderdonk A. B., Crabb J., Bartlett J. G. 1979; Protective efficacy of immunisation with capsular antigen against experimental infection with Bacteroides fragilis . Journal of Infectious Diseases 140:724–731
   [Google Scholar]
10. Kasper Weintraub A., Lonngren J. 1983; Capsular polysaccharides and lipopolysaccharides from two Bacteroides fragilis reference strains: chemical and immunochemical characterization. Journal of Bacteriology 153:991–997
    [Google Scholar]
11. Namavar F., Bal M., de Graaff J., MacLaren D. M. 1983; Effect of aerobic bacteria on killing of Proteus mirabilis by human polymorphonuclear leukocytes. Infection and Immunity 40:930–935
    [Google Scholar]
12. Nygren H., Dahlen G., Nilsson L.-A. 1979; Human complement activation by lipopolysaccharides from Bacteroides oralis, Fusobacterium nucleatum and Veillonella parvula . Infection and Immunity 26:391–396
    [Google Scholar]
13. Okuda K., Yanagi K., Takazoe I. 1978; Complement activation by Propionobacterium acnes and Bacteroides melaninogenicus . Archives of Oral Biology 23:911–915
    [Google Scholar]
14. Onderdonk A. B., Kasper D. L., Cisneros R. L., Bartlett J. G. 1977; The capsular polysaccharide of Bacteroidesfragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains. Journal of Infectious Diseases 136:82–89
    [Google Scholar]
15. Stendahl O., Edebo L. 1972; Phagocytosis of mutants of Salmonella typhimurium by rabbit polymorphonuclear cells. Acta Pathologica et Microbiologica Scandinavica B80:481–488
    [Google Scholar]
16. Sundqvist GK., Carlsson J., Herrmann BF., Hofling JF., Vaatainen A. 1984; Degradation in vivo of the C3 protein of guinea- pig complement by a pathogenic strain of Bacteroides gingivalis . Scandinavian Journal of Dental Research 92:1424
    [Google Scholar]
17. Sundqvist Carlsson J., Herrmann B., Tarnvik A. 1985; Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black–pigmented Bacteroides . Journal of Medical Microbiology 19:85–94
    [Google Scholar]
18. Tofte R. W., Peterson P. K., Schmeling D., Bracke J., Kim Y., Quie P. G. 1980; Opsonisation of four Bacteroides species: role of the classical complement pathway and immunoglobulin. Infection and Immunity 27:784–792
    [Google Scholar]
19. Vel W., Namavar F., Pubben A., MacLaren D. M. 1985; Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis . Journal of Clinical Pathology 38:86–91
    [Google Scholar]
20. Verhoef J., Quie P. G. 1977; Kinetics of staphylococcal opsonisation, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using (3H) thymidine labelled bacteria. Journal of Immunological methods 14:303–311
    [Google Scholar]
21. Wade B. H., Kasper D. L., Mandell G. L. 1983; Interactions of Bacteroides fragilis and phagocytes: studies with whole organisms, purified capsular polysaccharide and clindamycin-treated bacteria. Journal of Antimicrobial Chemotherapy 12: suppl C51–62
    [Google Scholar]
22. Wood W. B. 1960; Phagocytosis with particular reference to encapsulated bacteria. Bacteriological Reviews 24:41–49
    [Google Scholar]
23. Wilkinson B. J., Peterson P. K., Quie P. G. 1979; Cryptic peptidogly- can and the antiphagocytic effect of the Staphylococcus aureus capsule: Model for the antiphagocytic effect of bacterial cell surface polymers. Infection and Immunity 23:502–508
    [Google Scholar]